CAR T Cell Therapy: The Science and Patient Journey

Bristol Myers Squibb
August 6, 2020

Bristol Myers Squibb is proud to present CAR T Cell Therapy: The Science and Patient Journey at ONS Bridge 2020. Our speaker, Jean Treacy, MSN, APRN-BC, a Senior Clinical Nurse Consultant at Bristol Myers Squibb, will provide a detailed overview of CAR T cell therapy and the treatment process.

This presentation will help you understand the science behind this novel immunotherapy. You’ll learn about the CAR T cell therapy patient journey and key steps in the treatment process, as well as the multidisciplinary treatment team that supports them. 

The presentation will close with information about select side effects associated with CAR T cell therapy. 

Please join us for this presentation on Tuesday, September 15^th from 9:00-10:00am ET.

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, visit www.bms.com.